Chinese startup Guoke Xinglian has secured ¥100M ($14.6M) in Series A+ funding to scale up its precision-fermented human milk ...
Executives from Spruce Biosciences (NASDAQ:SPRB) outlined regulatory plans, clinical data highlights, and commercial considerations for the company’s lead program in Sanfilippo syndrome type B (MPS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results